vimarsana.com

Page 3 - ப்ராடக்ட்ஸ் வழங்கப்பட்டது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hemostasis/Coagulation Analyzer Market by Product (Clinical Laboratory, consumables, reagents, PoCT, Manual, Automated), Test (PT,Fibrinogen,APTT, ACT, D Dimer), Technology, End User -Forecast to 2025 – KSU

World Electric Bus (BEV, PHEV & FCEV) Market Report 2021-2027: New Revenue Pockets in Asia-Pacific and Northern Europe

The "Electric Bus Market by Propulsion (BEV, PHEV & FCEV), Application (Intercity & Intra-city), Consumer Segment (Fleet Operators & Government), Range, Length of Bus, Power Output, Battery Capacity, Component, Battery type & Region - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

Research and Markets: World Electric Bus (BEV, PHEV & FCEV) Market Report 2021-2027: New Revenue Pockets in Asia-Pacific and Northern Europe

Research and Markets: World Electric Bus (BEV, PHEV & FCEV) Market Report 2021-2027: New Revenue Pockets in Asia-Pacific and Northern Europe - ResearchAndMarkets.com ResearchAndMarkets.com s offering. The global electric bus market size is projected to grow from 81 thousand units in 2021 to reach 704 thousand units by 2027, at a CAGR of 43.1%. The advancements in battery pack technologies and electric powertrains are some of the major factors driving the growth of the electric bus and coach market. Many countries are focusing on the electrification of their mass transit solutions, especially buses and coaches. Factors such as rise in pollution and environmental hazards, stringent government regulations, and stiff competition have compelled automotive OEMs to make fuel-efficient and environment-friendly buses.

Global Industrial Internet of Things Markets 2021-2026 - Manufacturing and Healthcare to be Leading Verticals for IIoT Market Solutions

Increasing Demand of Smart Inhalers Market by 2026 | Novartis AG, BoehringerIngelheim International GmbH, Teva Pharmaceutical Industries

Increasing Demand of Smart Inhalers Market by 2026 | Novartis AG, BoehringerIngelheim International GmbH, Teva Pharmaceutical Industries iCrowd Newswire 06 May 2021, 18:25 GMT+10 The drugs used in the inhalers include anti-cholinergic, glucocorticoids, insulin, and beta-agonists for the treatment and prevention of respiratory diseases such as asthma and chronic obstructive pulmonary diseases. These inhalers are termed smart inhalers, owing to the sensors attached as a clip on to the inhalers monitoring the right dose per intake and the technique used for inhaling the medication. The data acquired by the sensor is shared with the patient and healthcare professionals to track their inhaler usage The market growth of smart inhalers can be attributed to factors such as the growing geriatric population globally and the rising number of patients suffering from respiratory diseases. According to the Office of Disease Prevention and Health Promotion, more than 25 million in the U.S. are

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.